Medidata
Depends
Confidence: Medium
Buy if you run regulated, multi-site clinical trials and can absorb enterprise pricing and implementation.
New check
Comparison
Medidata and Projectredcap both land on Depends.
Buy if you run regulated, multi-site clinical trials and can absorb enterprise pricing and implementation.
Buy in if you're a research or clinical team whose institution already hosts REDCap.
| Compare | ||
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Sponsors running regulated Phase II-III trials | Clinical and academic research teams |
| Who it's not for | Academic or pilot studies | Small teams needing a simple contact list or basic survey |
| Privacy | No known public vulnerabilities found in the sources reviewed.⁸ | Self-hosted research platform with several historical CVEs (SQL injection, XSS, CSRF), all disclosed 2017-2022 against older versions. |
| Support quality | No usable review evidence | Community forums; support depends on local institution |
| Public sentiment | G2 and Gartner reviews are broadly positive, while Reddit threads debate whether Rave's price and weight are justified.¹ | Researchers value its flexibility for study data capture, but report setup friction, mobile display quirks, and performance issues on large projects. |
| Biggest gotcha | Guess: validated study builds create lock-in; switching EDC mid-program is costly | Cannot self-sign-up: access requires a consortium partner institution or self-hosting. |